ReviewFrontiers in digital health2025
How the world of biobanking is changing with artificial intelligence.
Review in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Microbial biobanking: safeguarding the tiny treasures for sustainable human welfare.Folia microbiologica · 2026Review
- Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance.Frontiers in antibiotics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial Intelligence is increasingly shaping the practice of biobanking by influencing how biobanks evolve and operate, especially when it concerns their relationship to data. By assessing four key parameters-size, site, speed, and access-this paper analyzes the impact of AI technologies on biobanks, presenting them as dynamic boundary objects that produce biovalue by transforming biological material and data into intangible assets of the data-driven bioeconomy. Historically rooted at the intersection of health research and healthcare, biobanking is continually reshaped by emerging technologies, policies, and societal expectations. While biobanks were originally defined as collections of samples and associated data, they have recently evolved into complex infrastructures for both data and samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.